Works

Every work in the frame. Each row carries the routes that admitted it, because a frame that forgets how it found something cannot be audited.

Route

Field

Type

Language

Year range

Screen consensus

Sort

Flags

RetractedNo abstract

1 filter active

9,823 workspage 3 of 393

aff

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy

2021· article· en· Clinical Pharmacology & Therapeutics· Pharmacology, Toxicology and Pharmaceutics

399

citations

aff

Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method.

2000· review· en· Pharmacogenetics· Pharmacology, Toxicology and Pharmaceutics

397

citations

afffundno abstract

A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel

2003· article· en· European Journal of Pharmaceutics and Biopharmaceutics· Pharmacology, Toxicology and Pharmaceutics

375

citations

aff

Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems

2013· review· en· ISRN Pharmaceutics· Pharmacology, Toxicology and Pharmaceutics

374

citations

affno abstract

FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms

2003· article· en· AAPS PharmSciTech· Pharmacology, Toxicology and Pharmaceutics

370

citations

fundno aff

The Productive Merger of Iodonium Salts and Organocatalysis: A Non-photolytic Approach to the Enantioselective α-Trifluoromethylation of Aldehydes

2010· article· en· Journal of the American Chemical Society· Pharmacology, Toxicology and Pharmaceutics

363

citations

fundno aff

Ionic liquids for oral insulin delivery

2018· article· en· Proceedings of the National Academy of Sciences· Pharmacology, Toxicology and Pharmaceutics

363

citations

aff

Synthetic approaches to monofluoroalkenes

2011· review· en· Chemical Society Reviews· Pharmacology, Toxicology and Pharmaceutics

357

citations

aff

Chitosan Nanoparticles at the Biological Interface: Implications for Drug Delivery

2021· review· en· Pharmaceutics· Pharmacology, Toxicology and Pharmaceutics

351

citations

affno abstract

An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures

2000· article· en· Phytomedicine· Pharmacology, Toxicology and Pharmaceutics

350

citations

afffundno abstract

Characterization of thermosensitive chitosan gels for the sustained delivery of drugs

2000· article· en· International Journal of Pharmaceutics· Pharmacology, Toxicology and Pharmaceutics

345

citations

aff

An overview of forensic drug testing methods and their suitability for harm reduction point-of-care services

2017· review· en· Harm Reduction Journal· Pharmacology, Toxicology and Pharmaceutics

343

citations

afffund

Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system

2011· article· en· Proceedings of the National Academy of Sciences· Pharmacology, Toxicology and Pharmaceutics

342

citations

aff

Fluorine Transfer to Alkyl Radicals

2012· article· en· Journal of the American Chemical Society· Pharmacology, Toxicology and Pharmaceutics

335

citations

venueno aff

Kinetic Analysis of Drug Release From Nanoparticles

2008· article· en· Journal of Pharmacy & Pharmaceutical Sciences· Pharmacology, Toxicology and Pharmaceutics

334

citations

aboutno aff

Warfarin: almost 60 years old and still causing problems

2006· article· en· British Journal of Clinical Pharmacology· Pharmacology, Toxicology and Pharmaceutics

332

citations

affabout

Relative Enzymatic Activity, Protein Stability, and Tissue Distribution of Human Steroid-Metabolizing UGT2B Subfamily Members**This work was supported by the Medical Research Council of Canada, the Fonds de la Recherche en Sante du Quebec, and Endorecherche.

2001· article· en· Endocrinology· Pharmacology, Toxicology and Pharmaceutics

330

citations

affno abstract

N-acylated chitosan: hydrophobic matrices for controlled drug release

2003· article· en· Journal of Controlled Release· Pharmacology, Toxicology and Pharmaceutics

329

citations

fundno affno abstract

Clinical administration of microneedles: skin puncture, pain and sensation

2008· article· en· Biomedical Microdevices· Pharmacology, Toxicology and Pharmaceutics

329

citations

fundno aff

Opportunities and challenges in the diagnostic utility of dermal interstitial fluid

2023· review· en· Nature Biomedical Engineering· Pharmacology, Toxicology and Pharmaceutics

325

citations

aff

The Vexing Problem of Guidelines and Conflict of Interest: A Potential Solution

2010· article· en· Annals of Internal Medicine· Pharmacology, Toxicology and Pharmaceutics

322

citations

affno abstract

Responding to global stimulant use: challenges and opportunities

2019· review· en· The Lancet· Pharmacology, Toxicology and Pharmaceutics

319

citations

aboutno aff

2.1 Å Crystal Structure of Human PXR in Complex with the St. John's Wort Compound Hyperforin,

2003· article· en· Biochemistry· Pharmacology, Toxicology and Pharmaceutics

317

citations

afffund

Simple and Clean Photoinduced Aromatic Trifluoromethylation Reaction

2016· article· en· Journal of the American Chemical Society· Pharmacology, Toxicology and Pharmaceutics

316

citations

aff

Adverse reactions to first-line antituberculosis drugs

2006· review· en· Expert Opinion on Drug Safety· Pharmacology, Toxicology and Pharmaceutics

316

citations

← previous next →